0001183740-19-000020.txt : 20190130
0001183740-19-000020.hdr.sgml : 20190130
20190129200035
ACCESSION NUMBER: 0001183740-19-000020
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190130
DATE AS OF CHANGE: 20190129
EFFECTIVENESS DATE: 20190130
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCEPTION HOLDINGS, INC.
CENTRAL INDEX KEY: 0001757785
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-331697
FILM NUMBER: 19550085
BUSINESS ADDRESS:
STREET 1: 1500 - 1055 WEST GEORGIA ST
CITY: VANCOUVER
STATE: A1
ZIP: V6E 4N7
BUSINESS PHONE: 604-689-9111
MAIL ADDRESS:
STREET 1: 1500 - 1055 WEST GEORGIA ST
CITY: VANCOUVER
STATE: A1
ZIP: V6E 4N7
D
1
primary_doc.xml
X0708
D
LIVE
0001757785
CONCEPTION HOLDINGS, INC.
3E 3RD AVENUE
SAN MATEO
CA
CALIFORNIA
94401
5035933023
BRITISH COLUMBIA, CANADA
None
None
Corporation
true
2018
BRUCE
DAVID
VOSBURG
3 E 3RD AVENUE
CALIFORNIA
X1
UNITED STATES
94401
Executive Officer
Director
RALPH
RISCH
3 E 3RD AVENUE
CALIFORNIA
X1
UNITED STATES
94401
Executive Officer
Director
KEVIN
BROOKS
3 E 3RD AVENUE
CALIFORNIA
X1
UNITED STATES
94401
Executive Officer
Director
NISHAN
KARASSIK
3 E 3RD AVENUE
CALIFORNIA
X1
UNITED STATES
94401
Promoter
Director and executive officer of Phylos Bioscience, Inc., a promoter of the Issuer.
SCOTT
BOWMAN
3 E 3RD AVENUE
CALIFORNIA
X1
UNITED STATES
94401
Promoter
Director and executive officer of Phylos Bioscience, Inc., a promoter of the Issuer.
TIMOTHY
GREGORY
3 E 3RD AVENUE
CALIFORNIA
X1
UNITED STATES
94401
Promoter
Director of Phylos Bioscience, Inc., a promoter of the Issuer.
SONIA
LO
3 E 3RD AVENUE
CALIFORNIA
X1
UNITED STATES
94401
Promoter
Director and executive officer of Crop One Alternative Medicine Licensing, LLC, a promoter of the Issuer.
Other
Decline to Disclose
- 06b
false
2018-10-15
false
true
true
false
0
900000
0
900000
Total Offering Amount represents principal amount of unsecured convertible debentures (900 x $1000). The debentures are convertible into common shares with no further payment upon certain financing event.
false
10
0
0
0
false
CONCEPTION HOLDINGS, INC.
/s/ Kevin Brooks
Kevin Brooks
CEO
2019-01-24